ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

173 filings reported holding SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 63,765,651 shares of 98,567,360 outstanding shares and own 64.69% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (11,077,927 shares), RA CAPITAL MANAGEMENT, L.P. (10,860,977 shares), ORBIMED ADVISORS LLC (8,288,510 shares), BlackRock, Inc. (4,245,974 shares), SR One Capital Management, LP (4,012,903 shares), VANGUARD GROUP INC (3,349,296 shares), FRANKLIN RESOURCES INC (2,837,252 shares), STATE STREET CORP (2,049,542 shares), GEODE CAPITAL MANAGEMENT, LLC (1,234,805 shares), and Nextech Invest Ltd. (1,113,029 shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.